Zhitong Finance App learned that Bambusa Therapeutics Inc. (BBTX.US) has submitted an initial public offering and plans to raise funds to develop clinical trials of drugs to treat eczema and other inflammatory diseases.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.